{
    "organizations": [],
    "uuid": "1c86f0145003a5defe8e8184f370d4631e6c13b2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sage-therapeutics-submits-new-drug/brief-sage-therapeutics-submits-new-drug-application-to-u-s-fda-for-intravenous-brexanolone-in-the-treatment-of-postpartum-depression-idUSASC09WQX",
    "ord_in_thread": 0,
    "title": "Sage Therapeutics Submits New Drug Application To U.S. FDA For Intravenous Brexanolone In The Treatment Of Postpartum Depression",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News  15 AM / Updated 8 minutes ago BRIEF-Sage Therapeutics Submits New Drug Application To U.S. FDA For Intravenous Brexanolone In The Treatment Of Postpartum Depression Reuters Staff 1 Min Read \nApril 23 (Reuters) - SAGE Therapeutics Inc: \n* SAGE THERAPEUTICS SUBMITS NEW DRUG APPLICATION TO U.S. FDA FOR INTRAVENOUS BREXANOLONE IN THE TREATMENT OF POSTPARTUM DEPRESSION \n* SAGE THERAPEUTICS SUBMITS NEW DRUG APPLICATION TO U.S. FDA FOR INTRAVENOUS BREXANOLONE IN THE TREATMENT OF POSTPARTUM DEPRESSION \n* SAGE THERAPEUTICS - NDA SUBMISSION SUPPORTED BY DATA FROM HUMMINGBIRD PROGRAM Source text for Eikon: Further company coverage:",
    "published": "2018-04-23T19:15:00.000+03:00",
    "crawled": "2018-04-23T14:28:19.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "submits",
        "new",
        "drug",
        "application",
        "fda",
        "intravenous",
        "brexanolone",
        "treatment",
        "postpartum",
        "depression",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "sage",
        "therapeutic",
        "inc",
        "sage",
        "therapeutic",
        "submits",
        "new",
        "drug",
        "application",
        "fda",
        "intravenous",
        "brexanolone",
        "treatment",
        "postpartum",
        "depression",
        "sage",
        "therapeutic",
        "submits",
        "new",
        "drug",
        "application",
        "fda",
        "intravenous",
        "brexanolone",
        "treatment",
        "postpartum",
        "depression",
        "sage",
        "therapeutic",
        "nda",
        "submission",
        "supported",
        "data",
        "hummingbird",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}